S&P 500   4,586.91 (+0.83%)
DOW   36,140.09 (+0.24%)
QQQ   391.25 (+1.61%)
AAPL   194.38 (+1.07%)
MSFT   371.02 (+0.60%)
META   327.48 (+3.16%)
GOOGL   137.30 (+5.60%)
AMZN   147.06 (+1.76%)
TSLA   241.67 (+0.96%)
NVDA   465.04 (+2.20%)
NIO   7.52 (-2.97%)
BABA   72.27 (+1.09%)
AMD   128.09 (+9.65%)
T   17.08 (+0.83%)
F   10.84 (+1.40%)
MU   74.17 (+1.42%)
CGC   0.73 (+4.19%)
GE   119.03 (-0.65%)
DIS   92.71 (+1.32%)
AMC   6.88 (+1.33%)
PFE   28.80 (+0.03%)
PYPL   58.85 (-1.14%)
XOM   98.35 (-0.77%)
S&P 500   4,586.91 (+0.83%)
DOW   36,140.09 (+0.24%)
QQQ   391.25 (+1.61%)
AAPL   194.38 (+1.07%)
MSFT   371.02 (+0.60%)
META   327.48 (+3.16%)
GOOGL   137.30 (+5.60%)
AMZN   147.06 (+1.76%)
TSLA   241.67 (+0.96%)
NVDA   465.04 (+2.20%)
NIO   7.52 (-2.97%)
BABA   72.27 (+1.09%)
AMD   128.09 (+9.65%)
T   17.08 (+0.83%)
F   10.84 (+1.40%)
MU   74.17 (+1.42%)
CGC   0.73 (+4.19%)
GE   119.03 (-0.65%)
DIS   92.71 (+1.32%)
AMC   6.88 (+1.33%)
PFE   28.80 (+0.03%)
PYPL   58.85 (-1.14%)
XOM   98.35 (-0.77%)
S&P 500   4,586.91 (+0.83%)
DOW   36,140.09 (+0.24%)
QQQ   391.25 (+1.61%)
AAPL   194.38 (+1.07%)
MSFT   371.02 (+0.60%)
META   327.48 (+3.16%)
GOOGL   137.30 (+5.60%)
AMZN   147.06 (+1.76%)
TSLA   241.67 (+0.96%)
NVDA   465.04 (+2.20%)
NIO   7.52 (-2.97%)
BABA   72.27 (+1.09%)
AMD   128.09 (+9.65%)
T   17.08 (+0.83%)
F   10.84 (+1.40%)
MU   74.17 (+1.42%)
CGC   0.73 (+4.19%)
GE   119.03 (-0.65%)
DIS   92.71 (+1.32%)
AMC   6.88 (+1.33%)
PFE   28.80 (+0.03%)
PYPL   58.85 (-1.14%)
XOM   98.35 (-0.77%)
S&P 500   4,586.91 (+0.83%)
DOW   36,140.09 (+0.24%)
QQQ   391.25 (+1.61%)
AAPL   194.38 (+1.07%)
MSFT   371.02 (+0.60%)
META   327.48 (+3.16%)
GOOGL   137.30 (+5.60%)
AMZN   147.06 (+1.76%)
TSLA   241.67 (+0.96%)
NVDA   465.04 (+2.20%)
NIO   7.52 (-2.97%)
BABA   72.27 (+1.09%)
AMD   128.09 (+9.65%)
T   17.08 (+0.83%)
F   10.84 (+1.40%)
MU   74.17 (+1.42%)
CGC   0.73 (+4.19%)
GE   119.03 (-0.65%)
DIS   92.71 (+1.32%)
AMC   6.88 (+1.33%)
PFE   28.80 (+0.03%)
PYPL   58.85 (-1.14%)
XOM   98.35 (-0.77%)

ICU Medical Stock Price, News & Analysis (NASDAQ:ICUI)

$86.77
+0.48 (+0.56%)
(As of 02:11 PM ET)
Compare
Today's Range
$84.88
$87.06
50-Day Range
$81.08
$119.29
52-Week Range
$78.28
$212.43
Volume
107,270 shs
Average Volume
229,832 shs
Market Capitalization
$2.09 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$216.00

ICU Medical MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
150.6% Upside
$216.00 Price Target
Short Interest
Bearish
6.27% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.47
Upright™ Environmental Score
News Sentiment
-1.00mentions of ICU Medical in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1.04 M Sold Last Quarter
Proj. Earnings Growth
11.39%
From $5.18 to $5.77 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.92 out of 5 stars

Medical Sector

678th out of 958 stocks

Surgical & Medical Instruments Industry

63rd out of 77 stocks


ICUI stock logo

About ICU Medical Stock (NASDAQ:ICUI)

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

ICUI Stock Price History

ICUI Stock News Headlines

ICU Medical, Inc. (NASDAQ:ICUI) VP Sells $152,203.87 in Stock
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
ICU Medical: Who Is Coming To The Rescue?
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
ICU Medical Announces Third Quarter 2023 Results
ICU Medical Inc (IC7.MU)
ICU Medical: Continued Disappointments
ICU Medical Q2 Earnings Summary
See More Headlines
Receive ICUI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/06/2023
Today
12/07/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/26/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ICUI
CUSIP
44930G10
Employees
14,500
Year Founded
1984

Price Target and Rating

Average Stock Price Target
$216.00
High Stock Price Target
$216.00
Low Stock Price Target
$216.00
Potential Upside/Downside
+152.7%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-74,290,000.00
Pretax Margin
-2.80%

Debt

Sales & Book Value

Annual Sales
$2.25 billion
Cash Flow
$15.40 per share
Book Value
$87.15 per share

Miscellaneous

Free Float
22,330,000
Market Cap
$2.06 billion
Optionable
Optionable
Beta
0.63

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report














ICUI Stock Analysis - Frequently Asked Questions

What is ICU Medical's stock price target for 2024?

0 Wall Street analysts have issued 1 year price objectives for ICU Medical's shares. Their ICUI share price targets range from $216.00 to $216.00. On average, they expect the company's stock price to reach $216.00 in the next year. This suggests a possible upside of 150.6% from the stock's current price.
View analysts price targets for ICUI
or view top-rated stocks among Wall Street analysts.

How have ICUI shares performed in 2023?

ICU Medical's stock was trading at $157.48 at the start of the year. Since then, ICUI shares have decreased by 45.3% and is now trading at $86.19.
View the best growth stocks for 2023 here
.

When is ICU Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 26th 2024.
View our ICUI earnings forecast
.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) announced its quarterly earnings results on Monday, November, 6th. The medical instruments supplier reported $1.23 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.29. The medical instruments supplier had revenue of $553.31 million for the quarter, compared to analysts' expectations of $554 million. ICU Medical had a positive trailing twelve-month return on equity of 6.53% and a negative net margin of 1.25%.

What ETFs hold ICU Medical's stock?

ETFs with the largest weight of ICU Medical (NASDAQ:ICUI) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), Principal Healthcare Innovators ETF (BTEC) and Fidelity Disruptive Medicine ETF (FMED).

What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical Chief Executive Officer Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among the company's employees.

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and Company (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Wellington Management Group LLP (6.58%), FMR LLC (4.66%), Fuller & Thaler Asset Management Inc. (4.20%), JPMorgan Chase & Co. (3.01%), Morgan Stanley (2.70%) and Victory Capital Management Inc. (2.62%). Insiders that own company stock include Christian B Voigtlander, Daniel Woolson, Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends
.

How do I buy shares of ICU Medical?

Shares of ICUI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:ICUI) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -